drugset / Trial / NCT07000318
CS-206 in Patients With Sickle Cell Disease
NaSingle-groupOpen-labelTreatment
Summary
The goal of this open label, single-arm clinical study is to learn about the safety and efficacy of CS-206 injection in treating sickle cell disease.
Timeline
- Start
- 2026-09-30
- Primary completion
- 2028-12-30
- Completion
- 2029-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CS-206 | Cell therapy | — | — |